Elizabeth Barrett
2021
In 2021, Elizabeth Barrett earned a total compensation of $4.2M as Chief Executive Officer at UroGen Pharma Ltd., a 71% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $315,618 |
|---|---|
| Option Awards | $2,230,095 |
| Salary | $739,025 |
| Stock Awards | $882,800 |
| Other | $45,128 |
| Total | $4,212,666 |
Barrett received $2.2M in option awards, accounting for 53% of the total pay in 2021.
Barrett also received $315.6K in non-equity incentive plan, $739K in salary, $882.8K in stock awards and $45.1K in other compensation.
Rankings
In 2021, Elizabeth Barrett's compensation ranked 3,170th out of 12,415 executives tracked by ExecPay. In other words, Barrett earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,170 out of 12,415 | 75th |
Division Manufacturing | 1,280 out of 5,505 | 77th |
Major group Chemicals And Allied Products | 524 out of 2,375 | 78th |
Industry group Drugs | 465 out of 2,096 | 78th |
Industry Pharmaceutical Preparations | 321 out of 1,546 | 79th |
Source: SEC filing on August 1, 2023.
Barrett's colleagues
We found one more compensation record of an executive who worked with Elizabeth Barrett at UroGen Pharma Ltd. in 2021.
2021
Jason Smith
UroGen Pharma Ltd.